Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2022
      • Annual Report 2021
      • Annual Report 2020
    • CGHE Publications
  • Partner programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
      • Tip-HepC Registry
      • TiP-HepC Systematic Review Results
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Hep C Elimination Tool
      • Access the Tool
      • User Guide
      • Frequently Asked Questions
    • Search resources
    • Technical Assistance Help Desk and Frequently Asked Questions
    • Toolkit: Birth Dose Vaccination in Africa
  • Webinars & Events
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH "Moving from Hepatitis Discovery to Elimination"
    • Treatment of HCV in Pregnancy for Hepatitis (TiP-HepC)
      • Webinar 1: Challenges
      • Webinar 2: Strategies
    • Search webinars
  • News
    • Announcements
    • Blog
    • Elimination Champions
    • Events
    • Newsletters
    • Press releases
    • Publications
    • Search
  • UN Group of Friends
  1. Home
  2. News
  3. News search

News search

Filter

  • Hepatitis B
  • Hepatitis C
  • Announcements
  • Blogs
  • Events
  • Newsletters
  • (-) Press releases
  • Publications
  • Argentina
  • Bangladesh
  • Brazil
  • Canada
  • Chile
  • China
  • Egypt
  • Georgia
  • Ghana
  • Japan
  • Korea (Republic of)
  • Malaysia
  • Mexico
  • Nigeria
  • Peru
  • Portugal
  • Scotland
  • Sierra Leone
  • Switzerland
  • Tanzania
  • Uganda
  • Ukraine
  • United Kingdom
  • United States of America
Displaying 1 - 12 of 15
  • Coalition hosts event calling for a UN Group of Friends to support global hepatitis elimination

    26 Sep 2022
  • Press Release: International partners call for a UN Group of Friends to support global hepatitis elimination

    19 Sep 2022
  • Hepatitis Groups Host Davos Panel to Discuss Financing for Viral Hepatitis Elimination

    18 May 2022
  • WHD: Coalition for Global Hepatitis Elimination and Local Partners in 30 Countries Launch National Hepatitis Elimination Profiles (N-HEP)

    28 Jul 2021
  • Announcing the 2021 Hepatitis Elimination Champions

    23 Jul 2021
  • WHO announces global HBsAg prevalence falls below 1%, reaching 2020 target

    27 Jul 2020
  • Media release: Leading Public Health Organizations Petition the United States Government for Continued US Support of WHO

    30 Jun 2020
  • Coalition for Global Hepatitis Elimination guides care of viral hepatitis during the COVID-19 pandemic

    21 May 2020
  • US FDA approves Epclusa for children

    19 Mar 2020
  • COVID-19 news: Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use

    13 Mar 2020
  • Gilead Sciences and NIH Initiate Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19

    13 Mar 2020
  • Breakthrough Device Designation to the Elecsys® GALAD score intended to aid diagnosis of early stage hepatocellular carcinoma

    06 Mar 2020

Pagination

  • Current page 1
  • Page 2
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://www.linkedin.com/company/coalition-for-global-hepatitis-elimination

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2023 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media